Monique R. Bidell

917 total citations
26 papers, 607 citations indexed

About

Monique R. Bidell is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Monique R. Bidell has authored 26 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Monique R. Bidell's work include Clostridium difficile and Clostridium perfringens research (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Monique R. Bidell is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Monique R. Bidell collaborates with scholars based in United States, Switzerland and Australia. Monique R. Bidell's co-authors include Thomas P. Lodise, J. Nicholas O’Donnell, Ronak G. Gandhi, Athena L V Hobbs, Nimish Patel, Ramy H. Elshaboury, Arthur Y. Kim, Eugene P. Rhee, Roby P. Bhattacharyya and Sagar U. Nigwekar and has published in prestigious journals such as Gastroenterology, Journal of the American Society of Nephrology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Monique R. Bidell

23 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monique R. Bidell United States 13 262 167 157 134 91 26 607
Emanuela Sozio Italy 15 275 1.0× 181 1.1× 76 0.5× 119 0.9× 87 1.0× 41 619
Ashish Bhargava United States 13 248 0.9× 204 1.2× 161 1.0× 319 2.4× 57 0.6× 58 860
Navaneeth Narayanan United States 14 286 1.1× 219 1.3× 62 0.4× 74 0.6× 71 0.8× 47 659
Marc Garnier France 11 135 0.5× 242 1.4× 316 2.0× 159 1.2× 42 0.5× 53 732
Simone Meini Italy 15 226 0.9× 89 0.5× 94 0.6× 134 1.0× 135 1.5× 41 755
Nadia Castaldo Italy 13 100 0.4× 160 1.0× 194 1.2× 223 1.7× 63 0.7× 40 512
Davide Pecori Italy 11 277 1.1× 130 0.8× 92 0.6× 141 1.1× 68 0.7× 21 518
Frantzeska Frantzeskaki Greece 14 272 1.0× 448 2.7× 234 1.5× 294 2.2× 100 1.1× 40 964
Ertuğrul Güçlü Türkiye 15 237 0.9× 159 1.0× 102 0.6× 74 0.6× 125 1.4× 64 688
Yanina Dubrovskaya United States 18 248 0.9× 368 2.2× 347 2.2× 294 2.2× 54 0.6× 52 879

Countries citing papers authored by Monique R. Bidell

Since Specialization
Citations

This map shows the geographic impact of Monique R. Bidell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monique R. Bidell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monique R. Bidell more than expected).

Fields of papers citing papers by Monique R. Bidell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monique R. Bidell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monique R. Bidell. The network helps show where Monique R. Bidell may publish in the future.

Co-authorship network of co-authors of Monique R. Bidell

This figure shows the co-authorship network connecting the top 25 collaborators of Monique R. Bidell. A scholar is included among the top collaborators of Monique R. Bidell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monique R. Bidell. Monique R. Bidell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reveles, Kelly R., Anne J Gonzales-Luna, Yoav Golan, et al.. (2024). Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study. Open Forum Infectious Diseases. 11(7). ofae341–ofae341. 1 indexed citations
3.
Dubberke, Erik R., et al.. (2023). 700 SAFETY AND EFFICACY OF RBX2660 IN REDUCING RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN IMMUNOCOMPROMISED PARTICIPANTS. Gastroenterology. 164(6). S–142. 1 indexed citations
4.
Feuerstadt, Paul, Carl V. Crawford, Xing Tan, et al.. (2023). Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection. Journal of Clinical Gastroenterology. 58(8). 818–824. 6 indexed citations
5.
Elshaboury, Ramy H., et al.. (2022). A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections. Microbiology Spectrum. 10(3). e0038422–e0038422. 5 indexed citations
6.
Bidell, Monique R., Athena L V Hobbs, & Thomas P. Lodise. (2022). Gut microbiome health and dysbiosis: A clinical primer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(11). 849–857. 60 indexed citations
7.
Bidell, Monique R., et al.. (2022). Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption. Journal of Pharmacy Practice. 36(4). 993–997. 1 indexed citations
8.
Elshaboury, Ramy H., Lisa M. Bebell, Monique R. Bidell, et al.. (2021). Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period. Therapeutic Advances in Infectious Disease. 8. 1998281485–1998281485. 5 indexed citations
9.
Bidell, Monique R. & Thomas P. Lodise. (2021). Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(11). 915–931. 26 indexed citations
10.
O’Donnell, J. Nicholas, et al.. (2021). Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection. International Journal of Antimicrobial Agents. 57(4). 106311–106311.
11.
Bidell, Monique R., Manjunath P. Pai, & Thomas P. Lodise. (2020). Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class. Antibiotics. 9(12). 905–905. 17 indexed citations
12.
Gandhi, Ronak G., Monique R. Bidell, Ramy H. Elshaboury, et al.. (2020). Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. Journal of the American Society of Nephrology. 31(7). 1384–1386. 136 indexed citations
13.
Gandhi, Ronak G., et al.. (2019). 756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin. Open Forum Infectious Diseases. 6(Supplement_2). S337–S338. 2 indexed citations
14.
Bidell, Monique R., Nimish Patel, & J. Nicholas O’Donnell. (2018). Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. Journal of Antimicrobial Chemotherapy. 73(10). 2643–2651. 37 indexed citations
15.
Bidell, Monique R. & Thomas P. Lodise. (2018). Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(12). 1205–1215. 21 indexed citations
16.
17.
18.
Bidell, Monique R., et al.. (2017). Relationship between vancomycin exposure and outcomes among patients with MRSA bloodstream infections with vancomycin Etest® MIC values of 1.5 mg/L: A pilot study. Diagnostic Microbiology and Infectious Disease. 88(3). 259–263. 13 indexed citations
19.
Bidell, Monique R., et al.. (2016). Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy. 5(3). 299–312. 25 indexed citations
20.
Lodise, Thomas P., Monique R. Bidell, Shawn D. Flanagan, et al.. (2016). Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy. 71(9). 2553–2558. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuela Sozio Breakdown of academic impact, for papers by Ashish Bhargava Breakdown of academic impact, for papers by Navaneeth Narayanan Breakdown of academic impact, for papers by Marc Garnier Breakdown of academic impact, for papers by Simone Meini Breakdown of academic impact, for papers by Nadia Castaldo Breakdown of academic impact, for papers by Davide Pecori Breakdown of academic impact, for papers by Frantzeska Frantzeskaki Breakdown of academic impact, for papers by Ertuğrul Güçlü Breakdown of academic impact, for papers by Yanina Dubrovskaya
Rankless by CCL
2026